Diseases & Disorders
(G45)
990 on File
MIDDLE EAST CYSTIC FIBROSIS ASSOCIATION
Financial strength (30%)
55/100
Reliability (20%)
45/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$91K
Total Revenue
$115K
Total Expenses
$52K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.8%
Fundraising Efficiency
N/A
Operating Reserve
5.41x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.8% | 83.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.4 mo | 11.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.6% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 93.4% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-54.7% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-29.7% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-25.8% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $91K | $115K | $52K | 96.8% | — |
| 2024 | $201K | $163K | $75K | 92.6% | 0 |
| 2023 | $305K | $310K | $37K | 92.6% | 0 |
| 2022 | $54K | $176K | $42K | 20.1% | — |
| 2021 | $181K | $88K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.